Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2021-04-05
2024-03-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
NCT05442957
Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer
NCT01432132
Building a Renewed ImaGe After Head & Neck Cancer Treatment
NCT03518671
Improving Self-Management in Head and Neck Cancer
NCT02409485
Pain Related to Head and Neck Cancer (HNC); Implementation and Evaluation of Self-care Measure Due to the Same Illness
NCT03089736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
H1a: Eighty percent of enrolled study participants who complete baseline self-report measures will complete the BIHNC Program.
H1b: Eighty percent of study participants completing the BIHNC Program will rate it acceptable on the intervention evaluation form.
Specific Aim 2: To assess the preliminary efficacy of BIHNC for reducing body image concerns in patients who have completed treatment for head and neck cancer and who have body image concerns.
H2: Body image scores will improve from pre- to post- intervention
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Body Image after Head and Neck Cancer Treatment
e-learning didactic module
Participants utilize e-learning
Personal reflection activities
Participants complete questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
e-learning didactic module
Participants utilize e-learning
Personal reflection activities
Participants complete questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Answer in the affirmative to at least one of two questions concerning dissatisfaction with the way their body looks or function
* Have clinically significant body image concerns as defined by (BIS score \> 10)
Exclusion Criteria
* Cognitive impairment that would preclude ability to provide informed consent
* Unable to read text on a computer screen
* Not able to read and understand English
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bethany Rhoten
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bethany Rhoten
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bethany Rhoten, PhD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VICC HN 2123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.